199 related articles for article (PubMed ID: 23593328)
1. Hydroxysteroid sulfotransferase SULT2B1b promotes hepatocellular carcinoma cells proliferation in vitro and in vivo.
Yang X; Xu Y; Guo F; Ning Y; Zhi X; Yin L; Li X
PLoS One; 2013; 8(4):e60853. PubMed ID: 23593328
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury.
Wang Z; Yang X; Chen L; Zhi X; Lu H; Ning Y; Yeong J; Chen S; Yin L; Wang X; Li X
Arch Toxicol; 2017 Jan; 91(1):271-287. PubMed ID: 27052460
[TBL] [Abstract][Full Text] [Related]
3. SULT2B1b promotes epithelial-mesenchymal transition through activation of the β-catenin/MMP7 pathway in hepatocytes.
Yang X; Du X; Sun L; Zhao X; Zhu J; Li G; Tian J; Li X; Wang Z
Biochem Biophys Res Commun; 2019 Mar; 510(4):495-500. PubMed ID: 30658852
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro.
Zhang X; Bai Q; Xu L; Kakiyama G; Pandak WM; Zhang Z; Ren S
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G344-55. PubMed ID: 22679001
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SULT2B1b is an independent prognostic indicator and promotes cell growth and invasion in colorectal carcinoma.
Hu L; Yang GZ; Zhang Y; Feng D; Zhai YX; Gong H; Qi CY; Fu H; Ye MM; Cai QP; Gao CF
Lab Invest; 2015 Sep; 95(9):1005-18. PubMed ID: 26121319
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
He D; Falany CN
Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease.
Zhang X; Xu Y; Bai Q; Li X; Han J; Hou Y; Ji Y; Zhang Z
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G87-G96. PubMed ID: 32475129
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol sulfate and cholesterol sulfotransferase inhibit gluconeogenesis by targeting hepatocyte nuclear factor 4α.
Shi X; Cheng Q; Xu L; Yan J; Jiang M; He J; Xu M; Stefanovic-Racic M; Sipula I; O'Doherty RM; Ren S; Xie W
Mol Cell Biol; 2014 Feb; 34(3):485-97. PubMed ID: 24277929
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SULT2B1b Promotes Angiogenesis in Human Gastric Cancer.
Chen W; Zhou H; Ye L; Zhan B
Cell Physiol Biochem; 2016; 38(3):1040-54. PubMed ID: 26937945
[TBL] [Abstract][Full Text] [Related]
10. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
[No Abstract] [Full Text] [Related]
12. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
[TBL] [Abstract][Full Text] [Related]
15. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
16. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.
Mok WC; Wasser S; Tan T; Lim SG
World J Gastroenterol; 2012 Jul; 18(27):3527-36. PubMed ID: 22826617
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.
Pan Z; Pan H; Zhang J; Yang Y; Liu H; Yang Y; Huang G; Ni J; Huang J; Zhou W
Biol Res; 2015 Mar; 48(1):18. PubMed ID: 25889525
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
20. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis.
Zhang D; Liu J; Wang Y; Chen J; Chen T
J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
